March 2016 – mesoestetic pharma group, a leading pharmaceutical laboratory specialising in dermocosmetics and aesthetic medicine for more than 30 years, presents mesofiller®: the latest generation of dermal implants based on reticulated hyaluronic acid to correct wrinkles and restore facial volume.

Four years of development were required to create this new range of high quality dermal implants with cross-linked hyaluronic acid. It is a monophasic transparent gel of non-animal origin and completely absorbable.

Mesofiller has the CE mark compliant with the European directive on medical devices, a guarantee of quality, safety and efficacy.

Mesofiller smooths and corrects depressions and wrinkles caused by skin ageing. It sculpts the facial features, creates volume, shapes and augments lips. Mesofiller achieves natural, immediate and long lasting results.

Two highly purified concentrations, ensuring optimal tolerance.

mesofiller global  Reticulated hyaluronic acid (20 mg/ml) medium wrinkles & lips and mesofiller intense  Reticulated hyaluronic acid (25 mg/ml) deep wrinkles & facial remodelling

mesoestetic innovation : densimatrix® Technology

The mesofiller range is based on DENSIMATRIX® technology, a revolutionary cross-linking method associated with an intensive purification process. This unique technology enables the cross-linked of 100% hyaluronic acid chains to ensure better resistance to enzymatic degradation and maximum purity.

mesofiller global and mesofiller intense are ideal to combine with other medical procedures  such as chemical peels, botulinum toxin, Mesotherapy and pulsed light, for highly personalised treatments.

Clinical proven efficiency

A clinical study conducted on mesofiller between January 2014 and November 2015 with 30 volunteers shown a considerable improvement in 100% of the cases.

Results obtained after a single session, without further treatments or retouching.